Nifty and Sensex Surge: Markets Close on a High Note
Indian stock markets ended positively on November 12, with Nifty 50 up 0.70% at 25,875.80 and BSE Sensex rising 0.71% to 84,466.51. Market breadth was bullish with 2,647 stocks advancing out of 4,584 traded. Bharat Forge, Britannia Industries, RateGain Travel Tech, and Vodafone Idea were among the buzzing stocks. Tata Power announced major investment plans, while Aurobindo Pharma and Lupin reported positive developments in their respective sectors.
*this image is generated using AI for illustrative purposes only.
Market Overview
The Indian stock markets concluded on a positive note on November 12, 2025, with both benchmark indices, Nifty 50 and BSE Sensex, registering significant gains.
| Index | Closing Price | Change | % Change |
|---|---|---|---|
| Nifty 50 | 25,875.80 | 180.85 | 0.70% |
| BSE Sensex | 84,466.51 | 595.19 | 0.71% |
Market Breadth
The overall market sentiment was bullish, as reflected in the market breadth:
| Category | Number of Scrips |
|---|---|
| Total Traded | 4,584 |
| Positive | 2,647 |
| Negative | 1,937 |
Buzzing Stocks
Several stocks made headlines during the trading session:
Bharat Forge
The company reported a decline in standalone net sales but saw improvement in EBITDA margins. The aerospace revenue is expected to grow significantly, with analysts providing mixed ratings.
Britannia Industries
Reported revenue growth of 4.1% and profit growth of 23.1%, despite temporary disruptions due to GST rate changes. The company expects aggressive topline growth going forward.
RateGain Travel Tech
Updated its FY26 financial guidance, boosting revenue growth forecast to 55-60% year-over-year. The company maintains its organic growth projection at 6-8% for FY26.
Vodafone Idea
Plans to increase 4G network coverage from 84% to 90% within a couple of quarters, requiring a capital expenditure of ₹40 billion.
Tata Power
Announced plans to invest ₹25,000 crore in capital expenditure this year, aiming to increase renewable capacity by 2-2.5 gigawatts annually.
Aurobindo Pharma
Reported consolidated revenue growth of 6% year-on-year to ₹8,286 crores, with strong performance in US, Europe, and growth markets.
Lupin
Commissioned a dedicated Oncology Block at its Vizag facility, enhancing capabilities for High Potent Active Pharmaceutical Ingredients.
MTAR Technologies
Secured orders worth ₹271.75 crores from an existing international client, to be completed by Q2 FY27.
Conclusion
The Indian stock markets demonstrated resilience and optimism, with both Nifty 50 and BSE Sensex closing in the green. The positive market breadth indicates a broad-based rally, while several companies across sectors reported significant developments and positive outlooks.
15
